Thrombin and MMP-9 Release from Skin Cells
Author Information
Author(s): Wang Li, Luo Jianmin, He Shaoheng
Primary Institution: The First Affiliated Hospital, Shantou University Medical College
Hypothesis
How does thrombin influence the release of MMP-9 from human dermal fibroblasts?
Conclusion
Thrombin is a potent stimulus for the release of proMMP-9 from human dermal fibroblasts, likely through the activation of the PAR-1 receptor and the JAK/STAT3 signaling pathway.
Supporting Evidence
- Thrombin induced proMMP-9 release from HDFs in a dose-dependent manner.
- Hirudin completely abolished thrombin's effect on proMMP-9 release.
- AG490, a JAK/STAT3 inhibitor, significantly reduced thrombin-induced proMMP-9 release.
Takeaway
Thrombin helps skin cells release a substance that is important for healing wounds. This happens through a specific pathway in the cells.
Methodology
The study involved primary cultured human dermal fibroblasts treated with thrombin, and the release of proMMP-2 and proMMP-9 was measured using gelatin zymography.
Potential Biases
Potential bias may arise from the use of a limited number of fibroblast donors.
Limitations
The study was limited to a small sample size and focused only on specific signaling pathways.
Participant Demographics
Four healthy donors aged 18 to 21 years provided foreskin samples for fibroblast culture.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website